DaVita Inc.
NYSE:DVAMedical - Care Facilities
+$1.60 today
- Market cap
- $10.18B
- Beta
- 0.91
- P/E (TTM)
- 18.2
- EPS (TTM)
- $11.60
Volume 1.12M
Average 0.84M
DVA Other Income / Expenses
Net non-operating gains and losses, such as investment results, currency effects, and one-off items.
DaVita Inc.NYSE: DVA
Other Income / Expenses · Q2 FY2026 · quarter ended Jun 2026
Other income / expenses remains negative
Q2 FY2026 other income / expenses was -$135.81M, compared with -$168.91M a year earlier. Trailing-twelve-month other income / expenses was -$641.88M.
Context
- Other income / expenses amounted to 4.9% of revenue in FY2025, up 0.5 pp from a year earlier.
- Other income / expenses grew in size in 3 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly other income / expenses holds near -$135.81M or moves back toward the trailing-twelve-month quarterly average of -$160.47M.
Sources:Income StatementText generated from reported figures; not investment advice.
Other Income / Expenses history
USD · from the income statement
- Latest · FY2025
- (663.79M) USD
- Year-over-year change
- -18.5%
| Period | Period end | Other Income / Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (663.79M) | -18.5% |
| FY2024 | 2024-12-31 | (560.09M) | -31.6% |
| FY2023 | 2023-12-31 | (425.69M) | -14.2% |
| FY2022 | 2022-12-31 | (372.78M) | -33.7% |
| FY2021 | 2021-12-31 | (278.88M) | — |
Other Income / Expenses vs competitors
How DVA compares with its peers on the latest reported figures
- Peers report in different currencies, so other income / expenses is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -1.1% is the lowest of 3, against a peer median of +23.1%.
- Other income / expenses amounts to 4.6% of revenue for DVA, versus a peer median of 1.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | -$209M USD | +28.2% | — | 1.8% | |
| LTM Jun 2026 | -€390.56M EUR | +18.1% | — | 2.0% | |
| LTM Jun 2026 | -$641.88M USD | -1.1% | — | 4.6% | |
| Peer median (excluding DVA) | — | +23.1% | — | 1.9% | |
Competitors are the stored peer set for DVA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 11.62B | 11.61B | 12.14B | 12.82B | 13.64B |
| Cost of Revenue | 7.97B | 8.21B | 8.32B | 8.6B | 9.96B |
| Gross Profit | 3.65B | 3.4B | 3.82B | 4.22B | 3.68B |
| Gross Margin | 31.4% | 29.3% | 31.5% | 32.9% | 27.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.2B | 1.36B | 1.47B | 1.54B | 1.67B |
| Operating Expenses | 1.85B | 2.06B | 2.22B | 2.13B | 1.67B |
| Depreciation & Amortization | 680.62M | 732.6M | 745.44M | 723.86M | 715.35M |
| EBITDA | 2.48B | 2.06B | 2.32B | 2.72B | 2.64B |
| EBITDA Margin | 21.4% | 17.7% | 19.1% | 21.3% | 19.4% |
| Operating Income | 1.8B | 1.34B | 1.6B | 2.09B | 2.01B |
| Operating Margin | 15.5% | 11.5% | 13.2% | 16.3% | 14.7% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 285.25M | 357.02M | 398.55M | 470.47M | 549.67M |
| Other Income / Expenses | (278.88M) | (372.78M) | (425.69M) | (560.09M) | (663.79M) |
| Income Before Tax | 1.52B | 966.28M | 1.18B | 1.53B | 1.35B |
| Pre-Tax Margin | 13.1% | 8.3% | 9.7% | 11.9% | 9.9% |
| Income Tax Expense | 306.73M | 198.09M | 220.12M | 279.66M | 293.11M |
| Net Income | 978.45M | 560.4M | 691.54M | 936.34M | 746.8M |
| Net Margin | 8.4% | 4.8% | 5.7% | 7.3% | 5.5% |
| EPS (Basic) | 9.30 | 5.88 | 7.62 | 11.02 | 9.72 |
| EPS (Diluted) | 8.90 | 5.71 | 7.42 | 10.73 | 9.51 |
| Weighted Avg Shares | 105.23M | 92.99M | 90.79M | 84.99M | 86.1M |
| Weighted Avg Shares (Diluted) | 109.95M | 95.83M | 93.18M | 87.27M | 88.1M |
DaVita Inc.
NYSE:DVA
Intrinsic Alpha fair value
Locked
Current Price
$161.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.